Citigroup Inc Amgen Inc Call Options Transaction History

Citigroup Inc

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $7.68 Million - $9.36 Million	-34,000 Reduced 73.91%	12,000 $2.9 Million
Q4 2022 Feb 09, 2023	BUY	$229.03 - $291.01 $7.33 Million - $9.31 Million	32,000 Added 228.57%	46,000 $12.1 Million
Q2 2022 Aug 10, 2022	SELL	$230.71 - $256.74 $43.4 Million - $48.3 Million	-188,000 Reduced 93.07%	14,000 $3.41 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $6.1 Million - $6.74 Million	27,800 Added 15.96%	202,000 $48.8 Million
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $4.75 Million - $5.44 Million	23,900 Added 15.9%	174,200 $39.2 Million
Q3 2021 Nov 10, 2021	BUY	$212.27 - $248.7 $31.9 Million - $37.4 Million	150,300 New	150,300 $32 Million

3,073

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.